- Home
- NMS vs DXR Comparison
NMS vs DXR Comparison
Compare NMS & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
N/A
Current Price
$10.85
Company Overview
Basic Information| Metric | NMS | DXR |
|---|---|---|
| Founded | 1993 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 73.2M | 59.0M |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | NMS | DXR |
|---|---|---|
| Price | $11.43 | $10.85 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 18.5K | 1.7K |
| Earning Date | 01-01-0001 | 02-27-2026 |
| Dividend Yield | ★ 4.11% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $1,446,345.00 |
| Revenue This Year | N/A | $44,935.22 |
| Revenue Next Year | N/A | $74.79 |
| P/E Ratio | ★ N/A | $33.83 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.98 | $8.56 |
| 52 Week High | $12.50 | $14.76 |
Technical Indicators
Market Signals| Indicator | NMS | DXR |
|---|---|---|
| Relative Strength Index (RSI) | 21.12 | 55.86 |
| Support Level | N/A | $9.79 |
| Resistance Level | $12.03 | $10.91 |
| Average True Range (ATR) | 0.16 | 0.40 |
| MACD | -0.08 | 0.01 |
| Stochastic Oscillator | 19.09 | 39.78 |
Price Performance
Historical Comparison NMS
DXR
About NMS Nuveen Minnesota Quality Municipal Income Fund
Nuveen Minnesota Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund's primary investment objective is current income exempt from both regular federal income taxes and Minnesota state income taxes and its secondary investment objective is the enhancement of portfolio value.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system.